序号 |
标题 |
次数 |
作者 |
发布时间 |
73936 |
DOTA-SA-mAb |
76 |
h |
2024-12-19 |
73937 |
(LLP2A-DOTA)(4)PEG(10000) |
69 |
h |
2024-12-19 |
73938 |
LLP2A-DOTA-聚乙二醇 LLP2A-DOTA-PEG |
68 |
h |
2024-12-19 |
73939 |
DOTA-AaLS/HER2Afb HER2Afb修饰DOTA缀合的AaLS-ST |
84 |
h |
2024-12-19 |
73940 |
DOTA-P4 Thz-Phe-D-Trp-Lys-Thr-DOTA DOTA的线型超短肽缀合物 |
92 |
h |
2024-12-19 |
73941 |
DOTA-BP DOTA偶联双膦酸盐 |
117 |
h |
2024-12-19 |
73942 |
DOTA缀合的p160肽基放射缀合物 DOTA-p160 |
93 |
h |
2024-12-19 |
73943 |
DOTA-氮氧化合物 DOTA-NOx |
84 |
h |
2024-12-19 |
73944 |
Er-DOTA 铒-DOTA配合物 |
83 |
h |
2024-12-19 |
73945 |
DOTA-SETSKSF DOTA偶联七个氨基酸残基组成的环肽抑制剂 |
130 |
h |
2024-12-19 |
73946 |
羧基Bn-DOTA p-COOH-Bn-DOTA |
77 |
h |
2024-12-19 |
73947 |
DOTA四酰肼钆(ⅲ)配合物 |
78 |
h |
2024-12-19 |
73948 |
3-Gd(III)-氨基乙基酰胺基-DOTA的缀合物 |
105 |
h |
2024-12-19 |
73949 |
TCO功能化的CC49抗体 TCO-CC49 |
166 |
h |
2024-12-19 |
73950 |
CLT1肽靶向Gd(III)螯合物 CLT1-dL-(Gd-DOTA) |
103 |
h |
2024-12-19 |
73951 |
DOTA-pNO(2)-Phe-c(DCys-Tyr-DTrp-Lys-Thr-Cys)DTyrNH |
118 |
h |
2024-12-19 |
73952 |
Gd-DOTA-PLGA-b-PEG 钆-四氮杂环十二烷四乙酸共轭的聚(乳酸-共-乙醇酸)-嵌段-聚(乙二醇)共聚物胶束 |
114 |
h |
2024-12-19 |
73953 |
DOTA聚乙二醇化星形共聚物纳米粒子 |
85 |
h |
2024-12-19 |
73954 |
镓-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-Leu-Thr-Val-Ser-Pro-Trp-Tyr |
108 |
h |
2024-12-19 |
73955 |
DOTA-C595 p-SCN-Bn-DOTA偶联C595抗体 |
136 |
h |
2024-12-19 |
73956 |
DOTA-Tyr3-奥曲肽 DOTA-Tyr3-TOC |
82 |
h |
2024-12-19 |
73957 |
DOTA-生物素-亲和素 DOTA-biotin-avidin |
58 |
h |
2024-12-19 |
73958 |
DOTA-AuNPs 螯合剂DOTA包覆金纳米颗粒 |
96 |
h |
2024-12-19 |
73959 |
PS-WSCS-DOTA-BBN 水溶性壳聚糖缀合的DOTA-铃蟾肽包覆的金纳米颗粒 |
74 |
h |
2024-12-19 |
73960 |
苄基DOTA Bn-DOTA |
181 |
h |
2024-12-19 |
73961 |
DOTA-LM3 生长抑素受体(SSTR)拮抗剂 |
100 |
h |
2024-12-19 |
73962 |
Ga-DOTA-MGS5 大环配体-靶向肽 |
97 |
h |
2024-12-19 |
73963 |
Re-cyc-DOTA-sst2-ANT复合物 |
92 |
h |
2024-12-19 |
73964 |
DOTA-SP DOTA-P物质(SP) |
99 |
h |
2024-12-19 |
73965 |
DOTA-MG45 DOTA偶联迷你胃泌素(MG45) |
95 |
h |
2024-12-19 |
73966 |
DOTA-甘露糖胺葡聚糖 DOTA-MADs |
82 |
h |
2024-12-19 |
73967 |
ICG-DOTA 大环配体DOTA修饰吲哚菁绿荧光染料 |
102 |
h |
2024-12-18 |
73968 |
DOTA-SSA 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)-生长抑素类似物(SSA) |
81 |
h |
2024-12-18 |
73969 |
DOTA螯合剂修饰[cPP(1-7) |
142 |
h |
2024-12-18 |
73970 |
DOTA-ALB-24 DOTA-4-(对碘苯基)丁酸酯-24 |
89 |
h |
2024-12-18 |
73971 |
DOTA-GGNle-CycMSH hex DOTA偶联新肽 |
110 |
h |
2024-12-18 |
73972 |
Zr-p-NO2Bn-DOTA异构体 锆-硝基苄基偶联DOTA螯合剂 |
104 |
h |
2024-12-18 |
73973 |
DOTA-PSMA-617 1,4,7,10-四氮杂环十五烷偶联PSMA-617 |
81 |
h |
2024-12-18 |
73974 |
DOTA-VAP-1 螯合剂DOTA偶联VAP-1靶向肽 |
140 |
h |
2024-12-18 |
73975 |
DOTA-GIP-C803 DOTA螯合剂缀合GIPC803肽 |
70 |
h |
2024-12-18 |
73976 |
DOTA-mPS 螯合剂DOTA修饰微米级聚苯乙烯 |
103 |
h |
2024-12-18 |
73977 |
DOTA-HBED-bisphosphonate DOTA-HBED-二膦酸盐 |
99 |
h |
2024-12-18 |
73978 |
CAS号:2226472-28-0 ,DBCO-PEG4-Val-Cit-PAB-PNP |
102 |
WYQ |
2024-12-18 |
73979 |
cas:2112738-09-5, Mal-PEG4-Val-Cit-PAB-PNP |
114 |
WYQ |
2024-12-18 |
73980 |
Mal-PEG8-Val-Cit-PAB-PNP,可以溶解于DCM、DMF、DMSO、THF等有机溶剂,以及水中。 |
121 |
WYQ |
2024-12-18 |